Home Search
innv - search results
If you're not happy with the results, please do another search
Adding Innovus Pharma (INNV) $2.50 to Watch List.
Fast Growing eCommerce and Direct to Consumer Pharma Company Announces 1st Foray into CBD and 2nd Major Off-Patent Blockbuster Drug to its...
Innovus Pharma (INNV) Partners With Lavasta’s 150 Member Sales Force for Female Sexual Arousal!
Dubai based Lavasta is a pharmaceutical marketing company that offers niched unique medications based on the latest scientific innovations that defy current...
Innovus (INNV) Zestra® Female Sexual Arousal Oils Featured in NY Times.
Erin Drought, a 28-year-old information technology consultant in Edmonton, Alberta, who says her sex drive evaporated after she began taking medicine for...
Coronavirus Stock Mania. 800% Gain, Seen in a Single Day on 180 Million Shares!
We've played many sector manias in the past (operative word 'play') such as solar, stem cells, restaurants, blockchain, marijuana, and patent monetization...
Innovus Pharma Reports 2Q 2019 of $6.8 million, a 27.7% Increase from Prior Quarter.
Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter...
Rogaine® Competitor Regoxidine™ Expected to Launch Second Half, 2019.
Innovus Pharma (INNV) Announces a Second Partnered United States OTC ANDA for Minoxidil 5% Foam for Men and Women.